Veterinary Medicines

Cazitel Plus Tablets for Dogs

Authorised
  • Praziquantel
  • Febantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Cazitel Plus Tablets for Dogs
Cazitel Tabletten für Hunde
Active substance:
  • Praziquantel
  • Febantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 2 tablets.The strips are packed into cartons containing 2 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 4tablets.The strips are packed into cartons containing 4 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 6tablets,The strips are packed into cartons containing 6 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 8tablets.The strips are packed into cartons containing 8 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10tablets.The strips are packed into cartons containing 10 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12tablets.The strips are packed into cartons containing 12 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14tablets.The strips are packed into cartons containing 14 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 16tablets.The strips are packed into cartons containing 16 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 18tablets.The strips are packed into cartons containing 18 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20tablets.The strips are packed into cartons containing 20 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12 tablets. The strips are packed into cartons containing 24 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 28 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 6 tablets. The strips are packed into cartons containing 30 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 16 tablets. The strips are packed into cartons containing 32 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12 tablets. The strips are packed into cartons containing 36 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 40 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 42 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 4 tablets. The strips are packed into cartons containing 44 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 16 tablets. The strips are packed into cartons containing 48 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10 tablets. The strips are packed into cartons containing 50 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 4 tablets. The strips are packed into cartons containing 52 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 56 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 60 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 70 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 80 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 84 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 18 tablets. The strips are packed into cartons containing 90 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 14 tablets. The strips are packed into cartons containing 98 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 100 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 8 tablets. The strips are packed into cartons containing 104 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 2 tablets. The strips are packed into cartons containing 106 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 120 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 140 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10 tablets. The strips are packed into cartons containing 150 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 180 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 200 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 12 tablets. The strips are packed into cartons containing 204 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 2 tablets. The strips are packed into cartons containing 206 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 10 tablets. The strips are packed into cartons containing 250 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 280 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 300 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 500 tablets
  • Individual strips composed of aluminium foil 30 µm/30 gsm extruded polythene, containing 20 tablets. The strips are packed into cartons containing 1000 tablets
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 1000 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 500 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 300 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 280 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 250 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 206 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 204 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 200 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 18 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 180 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 150 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 140 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 120 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 106 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 104 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 100 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 98 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 90 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 84 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 80 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 70 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 60 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 56 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 52 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 50 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 48 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 44 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 42 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 40 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 36 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 32 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 30 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 28 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 24 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 20 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 16 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 14 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 12 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 10 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 8 tablets. The blisters are packed into cartons containing 8 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 6 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 4 tablets.
  • Individual blisters composed of 45 µm, soft temper aluminium foil and 25 µm hard temper aluminium foil, containing 2 tablets. The blisters are packed into cartons containing 2 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401289.00.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0243/001
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 24/08/2025
Download
German (PDF)
Published on: 23/09/2025
Download

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Updated on: 23/09/2025
Download

ie-puar-mr-iev0243001-cazitel-plus-tablets-for-dogs-en.pdf

English (PDF)
Published on: 25/09/2024
Download